Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines

Influenza and other Respiratory Viruses

Volumn 7, Issue 4, 2013, Pages 521-530

  Getie Kebtie, Melkamu ^a   Sultana, Ishrat ^a   Eichelberger, Maryna ^a   Alterman, Michail ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Hemagglutinin; Influenza; Mass spectrometry; Neuraminidase; Proteomics

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; SIALIDASE; VIRUS PROTEIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG CONTAMINATION; DRUG POTENCY; INFLUENZA VIRUS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; STANDARD;

ANTIGENS, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA VACCINES; MASS SPECTROMETRY; NEURAMINIDASE; ORTHOMYXOVIRIDAE; TECHNOLOGY, PHARMACEUTICAL; VIROLOGY;

EID: 84879108183     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12001     Document Type: Article

References (16)

1. Webster RG, Bean WJ Jr. Genetics of influenza virus. Annu Rev Genet 1978; 12:415-431.
2. Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000; 69:531-569.
3. Who Expert Committee On Biological Standardization. Available at http://www.who.int/biologicals/expert_committee/BS2011.2183_Flu_vax_ERL_calibration_protocol.pdf, 17 to 21 October 2011. (Accessed 17 January 2012).
4. Harvey R, Wheeler JX, Wallis CL, Robertson JS, Engelhardt OG. Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1). Vaccine 2008; 26:6550-6554.
5. Olson BJ, Markwell J. Assays for determination of protein concentration. Curr Protoc Protein Sci 2007; Chapter 3:Unit 3.4; pp 3.4.1-3.4.29.
6. Kapteyn JC, Saidi MD, Dijkstra R et al. Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method. Vaccine 2006; 24:3137-3144.
7. Williams TL, Luna L, Guo Z et al. Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. Vaccine 2008; 26:2510-2520.
8. Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics 2006; 5:144-156.
9. Bostanci N, Heywood W, Mills K et al. Application of label-free absolute quantitative proteomics in human gingival crevicular fluid by LC/MS E (gingival exudatome). J Proteome Res 2010; 9:2191-2199.
10. Cheng FY, Blackburn K, Lin YM, Goshe MB, Williamson JD. Absolute protein quantification by LC/MS(E) for global analysis of salicylic acid-induced plant protein secretion responses. J Proteome Res 2009; 8:82-93.
11. Farnsworth A, Cyr TD, Li C, Wang J, Li X. Antigenic stability of H1N1 pandemic vaccines correlates with vaccine strain. Vaccine 2011; 29:1529-1533.
12. Getie-Kebtie M, Lazarev A, Eichelberger M, Alterman M. Label-free mass spectrometry-based relative quantification of proteins separated by one-dimensional gel electrophoresis. Anal Biochem 2011; 409:202-212.
13. Norrgran J, Williams TL, Woolfitt AR et al. Optimization of digestion parameters for protein quantification. Anal Biochem 2009; 393:48-55.
14. Sylte MJ, Suarez DL. Influenza neuraminidase as a vaccine antigen. Curr Top Microbiol Immunol 2009; 333:227-241.
15. Bright RA, Neuzil KM, Pervikov Y, Palkonyay L. WHO meeting on the role of neuraminidase in inducing protective immunity against influenza infection, Vilamoura, Portugal, September 14, 2008. Vaccine 2009; 27:6366-6369.
16. European Pharmacopoeia 5th Ed. Main Volume 5.0, European Directorate For The Quality Of Medic, 2004; 677.